Published in Endocrinology on January 15, 2004
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect (2008) 2.56
Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res (2008) 2.40
Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes (2010) 2.35
Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes (2009) 2.11
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ (2005) 1.90
AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med (2009) 1.88
L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res (2008) 1.80
Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr (2008) 1.80
Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) (2010) 1.71
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver (2012) 1.70
The major inflammatory mediator interleukin-6 and obesity. Inflamm Res (2009) 1.67
The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol (2009) 1.66
Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol (2009) 1.65
Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm (2010) 1.65
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2007) 1.61
Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One (2012) 1.59
Influence of exercise and perivascular adipose tissue on coronary artery vasomotor function in a familial hypercholesterolemic porcine atherosclerosis model. J Appl Physiol (1985) (2009) 1.53
Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia (2005) 1.47
Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One (2010) 1.38
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer (2010) 1.35
Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) (2004) 1.34
Adipose tissue mass and location affect circulating adiponectin levels. Diabetologia (2011) 1.32
Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol (2011) 1.30
Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes (2008) 1.29
Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J Gerontol A Biol Sci Med Sci (2009) 1.29
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes (2010) 1.28
Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surg (2010) 1.28
Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem (2005) 1.26
Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS One (2012) 1.25
Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract (2012) 1.25
Adipose tissue: friend or foe? Nat Rev Cardiol (2012) 1.24
Cardiovascular disease in childhood: the role of obesity. Eur J Pediatr (2013) 1.20
Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab (2010) 1.20
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Visceral and subcutaneous adiposity and brachial artery vasodilator function. Obesity (Silver Spring) (2009) 1.17
Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev (2007) 1.17
Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes (2008) 1.16
Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) (2008) 1.15
Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond) (2008) 1.15
Obesity in cancer survival. Annu Rev Nutr (2012) 1.13
Intrinsic depot-specific differences in the secretome of adipose tissue, preadipocytes, and adipose tissue-derived microvascular endothelial cells. Diabetes (2010) 1.13
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol (2011) 1.12
The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep (2012) 1.12
Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am J Physiol Endocrinol Metab (2010) 1.11
Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm (2013) 1.11
Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women. Obes Surg (2009) 1.10
Is obesity in women protective against osteoporosis? Diabetes Metab Syndr Obes (2011) 1.09
Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol (2008) 1.08
Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism (2009) 1.08
IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol (2011) 1.07
The EP3 Receptor: Exploring a New Target for Type 2 Diabetes Therapeutics. J Endocrinol Diabetes Obes (2015) 1.07
Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR Res (2008) 1.07
Adipose tissue biology and cardiomyopathy: translational implications. Circ Res (2012) 1.05
Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp Gerontol (2008) 1.05
Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology (2011) 1.05
Roles of IL-6-gp130 Signaling in Vascular Inflammation. Curr Cardiol Rev (2008) 1.04
Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes. Histochem Cell Biol (2005) 1.03
Effects of total and regional fat loss on plasma CRP and IL-6 in overweight and obese, older adults with knee osteoarthritis. Osteoarthritis Cartilage (2014) 1.01
Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells. J Biol Chem (2008) 1.01
Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue. Am J Physiol Endocrinol Metab (2008) 1.01
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPAR Res (2009) 1.01
Oxidative stress and the ageing endocrine system. Nat Rev Endocrinol (2013) 1.00
Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm IGF Res (2011) 1.00
Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications. Am J Infect Dis (2006) 1.00
The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol (2012) 1.00
Insulin signalling mechanisms for triacylglycerol storage. Diabetologia (2013) 1.00
Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance. Front Physiol (2015) 1.00
Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. J Appl Physiol (1985) (2012) 0.98
Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women. Am J Physiol Endocrinol Metab (2011) 0.98
Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis. PLoS One (2011) 0.98
Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver Spring) (2008) 0.98
The impact of adiposity on adipose tissue-resident lymphocyte activation in humans. Int J Obes (Lond) (2014) 0.97
Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative. Stroke (2010) 0.97
Role of nuclear receptor corepressor RIP140 in metabolic syndrome. Biochim Biophys Acta (2010) 0.96
mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. Int J Obes (Lond) (2009) 0.96
Centrally located body fat is associated with lower bone mineral density in older Puerto Rican adults. Am J Clin Nutr (2011) 0.96
Regulation of Microvascular Function by Adipose Tissue in Obesity and Type 2 Diabetes: Evidence of an Adipose-Vascular Loop. Am J Biomed Sci (2009) 0.95
Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity. Int J Hepatol (2012) 0.95
Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. J Clin Endocrinol Metab (2008) 0.94
Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol (2010) 0.94
The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2). BMC Biol (2009) 0.94
Differential expression and localization of 12/15 lipoxygenases in adipose tissue in human obese subjects. Biochem Biophys Res Commun (2010) 0.94
Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci (2015) 0.93
Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes (2014) 0.93
Severely obese have greater LPS-stimulated TNF-alpha production than normal weight African-American women. Obesity (Silver Spring) (2008) 0.93
T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding. PLoS One (2010) 0.93
Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity (Silver Spring) (2007) 0.93
Evidence and mechanisms of fat depletion in cancer. Nutrients (2014) 0.93
trans-10,cis-12-Conjugated linoleic acid instigates inflammation in human adipocytes compared with preadipocytes. J Biol Chem (2010) 0.92
The gp130 receptor cytokine family: regulators of adipocyte development and function. Curr Pharm Des (2011) 0.92
Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse. Invest Ophthalmol Vis Sci (2010) 0.92
Pharmacological and non-pharmacological interventions to influence adipose tissue function. Cardiovasc Diabetol (2011) 0.91
Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res (2016) 0.91
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90
The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK. J Diabetes Metab (2013) 0.90
Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. Cancer Causes Control (2010) 0.90
Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies. Mediators Inflamm (2010) 0.90
Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mellitus. Biochem Biophys Res Commun (2008) 0.90
A prospective, randomized trial of laparoscopic polytetrafluoroethylene (PTFE) patch repair vs simple cruroplasty for large hiatal hernia. Arch Surg (2002) 2.29
Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun (2003) 1.65
Non-closure of defects during laparoscopic Roux-en-Y gastric bypass. Obes Surg (2007) 1.44
Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab (2009) 1.43
Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab (2003) 1.43
Band versus bypass: randomization and patients' choices and perceptions. Surg Obes Relat Dis (2006) 1.41
Consumer-based technology for distribution of surgical videos for objective evaluation. Surg Endosc (2012) 1.40
AKAP79-mediated targeting of the cyclic AMP-dependent protein kinase to the beta1-adrenergic receptor promotes recycling and functional resensitization of the receptor. J Biol Chem (2006) 1.28
Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains. Mol Biol Cell (2010) 1.25
Assembly of an SAP97-AKAP79-cAMP-dependent protein kinase scaffold at the type 1 PSD-95/DLG/ZO1 motif of the human beta(1)-adrenergic receptor generates a receptosome involved in receptor recycling and networking. J Biol Chem (2006) 1.21
Characterization of the residues in helix 8 of the human beta1-adrenergic receptor that are involved in coupling the receptor to G proteins. J Biol Chem (2006) 1.20
Decrease in sweet taste in rats after gastric bypass surgery. Surg Endosc (2010) 1.09
Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism (2005) 1.08
What happens to patients who do not follow-up after bariatric surgery? Am Surg (2007) 1.07
Taste change after laparoscopic Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding. Surg Obes Relat Dis (2006) 1.06
Adult epicardial fat exhibits beige features. J Clin Endocrinol Metab (2013) 1.04
Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabolism (2008) 1.04
Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care (2011) 1.03
Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat. Metabolism (2010) 1.03
Expression of PH-20 in normal and neoplastic breast tissue. J Surg Res (2002) 1.01
Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg (2004) 0.98
Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs. Metabolism (2013) 0.97
Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg (2007) 0.95
Minimally invasive surgery for achalasia: a 10-year experience. J Gastrointest Surg (2004) 0.94
Epicardial fat gene expression after aerobic exercise training in pigs with coronary atherosclerosis: relationship to visceral and subcutaneous fat. J Appl Physiol (1985) (2010) 0.94
Selective use of esophageal manometry and 24-Hour pH monitoring before laparoscopic fundoplication. J Am Coll Surg (2003) 0.94
Laparoscopic repair of a recurrent chronic traumatic diaphragmatic hernia. Am Surg (2003) 0.93
Support group meeting attendance is associated with better weight loss. Obes Surg (2008) 0.93
Depot-specific overexpression of proinflammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis. Metab Syndr Relat Disord (2011) 0.91
Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg (2005) 0.91
Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring) (2009) 0.90
Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery. Surg Endosc (2008) 0.89
Role of the cyclic AMP-dependent protein kinase in homologous resensitization of the beta1-adrenergic receptor. J Biol Chem (2004) 0.89
Laparoscopic re-operations for band removal after open banded gastric bypass. Obes Surg (2007) 0.89
Hepatic gene expression in morbidly obese women: implications for disease susceptibility. Obesity (Silver Spring) (2009) 0.88
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg (2007) 0.88
Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone. Mol Cell Endocrinol (2008) 0.88
Nedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity. Endocrinology (2015) 0.87
Postoperative gastrointestinal complaints after laparoscopic Nissen fundoplication. JSLS (2006) 0.86
Inhibition of leptin release by atrial natriuretic peptide (ANP) in human adipocytes. Biochem Pharmacol (2003) 0.86
Role of AKAP79/150 protein in β1-adrenergic receptor trafficking and signaling in mammalian cells. J Biol Chem (2013) 0.86
Laparoscopic revision of failed fundoplication and hiatal herniorraphy. J Laparoendosc Adv Surg Tech A (2009) 0.85
Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue. Biochem Pharmacol (2005) 0.85
Laparoscopic repair of incarcerated diaphragmatic hernia with mesh. J Laparoendosc Adv Surg Tech A (2007) 0.84
Intraoperative endoscopy and leaks after laparoscopic Roux-en-Y gastric bypass. Am Surg (2009) 0.83
Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. Metabolism (2005) 0.83
Rab11a and its binding partners regulate the recycling of the ß1-adrenergic receptor. Cell Signal (2010) 0.82
SAP97 controls the trafficking and resensitization of the beta-1-adrenergic receptor through its PDZ2 and I3 domains. PLoS One (2013) 0.81
Laparoscopic repair of congenital duodenal obstruction. J Laparoendosc Adv Surg Tech A (2006) 0.81
Gastric bypass surgery in rats produces weight loss modeling after human gastric bypass. Obes Surg (2008) 0.80
Management of recurrent inguinal hernias after total extraperitoneal (TEP) herniorrhaphies. J Laparoendosc Adv Surg Tech A (2009) 0.80
Haptoglobin release by human adipose tissue in primary culture. J Lipid Res (2003) 0.80
The inflammatory response seen when human omental adipose tissue explants are incubated in primary culture is not dependent upon albumin and is primarily in the nonfat cells. J Inflamm (Lond) (2010) 0.79
Use of upper gastrointestinal studies after laparoscopic gastric bypass. Surg Endosc (2007) 0.79
Dexamethasone and the inflammatory response in explants of human omental adipose tissue. Mol Cell Endocrinol (2009) 0.78
Sorting of β1-adrenergic receptors is mediated by pathways that are either dependent on or independent of type I PDZ, protein kinase A (PKA), and SAP97. J Biol Chem (2013) 0.78
Surgical cricothyroidotomy in trauma patients. South Med J (2003) 0.77
Effect of preoperative knowledge on weight loss after laparoscopic gastric bypass. Obes Surg (2008) 0.77
Gastric emptying time, not enterogastric reflux, is related to symptoms after upper gastrointestinal/biliary surgery. Am J Surg (2002) 0.77
Regulation of leptin release by insulin, glucocorticoids, G(i)-coupled receptor agonists, and pertussis toxin in adipocytes and adipose tissue explants from obese humans in primary culture. Metabolism (2003) 0.76
Nonalcoholic fatty liver disease of obesity. Obes Surg (2006) 0.76
The hydrophobic amino acid cluster at the cytoplasmic end of transmembrane helix III modulates the coupling of the β(1)-adrenergic receptor to G(s). J Recept Signal Transduct Res (2013) 0.75
Band versus bypass: influence of an educational seminar and surgeon visit on patient preference. Surg Obes Relat Dis (2007) 0.75
Clinical diagnostics versus a theoretic algorithm in diagnosing abdominal pain. South Med J (2005) 0.75
Insurance mandated preoperative dietary counseling does not improve outcome and increases drop-out rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis (2006) 0.75
Metabolic surgery: not just weight loss surgery anymore. Surg Obes Relat Dis (2008) 0.75
Laparoscopic Roux-en-Y Gastric bypass utilizing the triple stapling technique. JSLS (2006) 0.75
Synchronous occurrence of glioblastoma multiforme and esophageal adenocarcinoma. Am Surg (2003) 0.75
Unsupervised procedures by surgical trainees: a windfall for private insurance at the expense of graduate medical education. J Trauma (2011) 0.75
Laparoscopic bariatric patients' will to help: the foundation of research. Surg Obes Relat Dis (2007) 0.75
Technical skills rotation for general surgery residents. J Surg Res (2009) 0.75
Laparoscopic omental-cerebellar pedicled graft harvest. Surg Laparosc Endosc Percutan Tech (2002) 0.75
Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists. Mol Pharmacol (2006) 0.75
Laparoscopic transgastric esophageal mucosal resection for high-grade dysplasia. J Laparoendosc Adv Surg Tech A (2004) 0.75